INPLASY202440048

Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis

Keywords: secondary autoimmune diseases, alemtuzumab, multiple sclerosis, side effects,meta-analysis.

Download PDF - 202440048

Review Status: completed and published